Soliris approved in China for the treatment of adults with refractory generalised myasthenia gravis – AstraZeneca
Soliris (eculizumab) has been approved in China for the treatment of adult patients with refractory generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the… read more.
